Spironolactone versus placebo for patients experiencing heart failure with preserved ejection fraction: The IMPRESS-AF randomized controlled trial

Eduard Shantsila, Farhan Shahid, Yongzhong Sun, Jon Deeks, Ronnie Haynes, Melanie Calvert, Fisher James P, Paulus Kirchhof, Paramjit Gill, Gregory Lip

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalNIHR Journals Library
Publication statusAccepted/In press - 9 Mar 2020

Cite this